Gene Therapy Platform Developed by Neena Haider, PhD, Granted FDA Orphan Drug Designation February 27, 2019 OCU400, a novel gene therapy platform developed by Neena Haider, PhD, Harvard Medical School Associate Professor of Ophthalmology and Associate Scientist at the Schepens Eye Research Institute of Mass... Read More Gene Therapy Platform Developed by Neena Haider, PhD, Granted FDA Orphan Drug Designation
